<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yu S</submitter><funding>R&amp;amp;D Program of Guangzhou National Laboratory</funding><funding>福 建 省 科 技 厅 | Natural Science Foundation of Fujian Province</funding><funding>MOST | National Natural Science Foundation of China (NSFC)</funding><funding>| Natural Science Foundation of Fujian Province (Fujian Natural Science Foundation)</funding><funding>R&amp;D Program of Guangzhou National Laboratory</funding><funding>The Fourteenth Five-Year National Key Reaech and Development Program of China</funding><funding>MOST | National Natural Science Foundation of China</funding><pagination>1367-1384</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11894153</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(5)</volume><pubmed_abstract>Cyclic diguanosine monophosphate (c-di-GMP) is a ubiquitous bacterial secondary messenger with diverse functions. A previous Escherichia coli proteome microarray identified that c-di-GMP binds to the 23S rRNA methyltransferases RlmI and RlmE. Here we show that c-di-GMP inhibits RlmI activity in rRNA methylation assays, and that it modulates ribosome assembly in the presence of kanamycin. Molecular dynamics simulation and mutagenesis studies reveal that c-di-GMP binds to RlmI at residues R64, R103, G114, and K201. Structural simulations indicate that c-di-GMP quenches RlmI activity by inducing the closure of the catalytic pocket. We also show that c-di-GMP promotes antibiotic tolerance through RlmI. Binding and methylation assays indicate that the inhibitory effect of c-di-GMP on RlmI is co</pubmed_abstract><journal>EMBO reports</journal><pubmed_title>c-di-GMP inhibits rRNA methylation and impairs ribosome assembly in the presence of kanamycin.</pubmed_title><pmcid>PMC11894153</pmcid><funding_grant_id>32000027</funding_grant_id><funding_grant_id>2022J01197</funding_grant_id><funding_grant_id>GZNL2023A01005</funding_grant_id><funding_grant_id>92374110</funding_grant_id><funding_grant_id>2023YFC2307200</funding_grant_id><pubmed_authors>Shen J</pubmed_authors><pubmed_authors>Yu S</pubmed_authors><pubmed_authors>Hu Z</pubmed_authors><pubmed_authors>Liang X</pubmed_authors><pubmed_authors>Liu M</pubmed_authors><pubmed_authors>Chen H</pubmed_authors><pubmed_authors>Xu X</pubmed_authors><pubmed_authors>Lin M</pubmed_authors><pubmed_authors>Tao SC</pubmed_authors><pubmed_authors>Xu Z</pubmed_authors><pubmed_authors>Marti J</pubmed_authors></additional><is_claimable>false</is_claimable><name>c-di-GMP inhibits rRNA methylation and impairs ribosome assembly in the presence of kanamycin.</name><description>Cyclic diguanosine monophosphate (c-di-GMP) is a ubiquitous bacterial secondary messenger with diverse functions. A previous Escherichia coli proteome microarray identified that c-di-GMP binds to the 23S rRNA methyltransferases RlmI and RlmE. Here we show that c-di-GMP inhibits RlmI activity in rRNA methylation assays, and that it modulates ribosome assembly in the presence of kanamycin. Molecular dynamics simulation and mutagenesis studies reveal that c-di-GMP binds to RlmI at residues R64, R103, G114, and K201. Structural simulations indicate that c-di-GMP quenches RlmI activity by inducing the closure of the catalytic pocket. We also show that c-di-GMP promotes antibiotic tolerance through RlmI. Binding and methylation assays indicate that the inhibitory effect of c-di-GMP on RlmI is co</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-06-02T19:18:17.199Z</modification><creation>2025-04-04T02:50:58.473Z</creation></dates><accession>S-EPMC11894153</accession><cross_references><pubmed>39870966</pubmed><doi>10.1038/s44319-025-00377-w</doi></cross_references></HashMap>